Cargando…
Current Treatment Approaches and Global Consensus Guidelines for Brain Metastases in Melanoma
BACKGROUND: Up to 60% of melanoma patients develop melanoma brain metastases (MBM), which traditionally have a poor diagnosis. Current treatment strategies include immunotherapies (IO), targeted therapies (TT), and stereotactic radiosurgery (SRS), but there is considerable heterogeneity across world...
Autores principales: | Tan, Xiang-Lin, Le, Amy, Lam, Fred C., Scherrer, Emilie, Kerr, Robert G., Lau, Anthony C., Han, Jiali, Jiang, Ruixuan, Diede, Scott J., Shui, Irene M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117744/ https://www.ncbi.nlm.nih.gov/pubmed/35600355 http://dx.doi.org/10.3389/fonc.2022.885472 |
Ejemplares similares
-
Systematic literature review and meta-analysis of clinical outcomes and prognostic factors for melanoma brain metastases
por: Tan, Xiang-Lin, et al.
Publicado: (2022) -
Burden and Risk Factors of Brain Metastases in Melanoma: A Systematic Literature Review
por: Tan, Xiang-Lin, et al.
Publicado: (2022) -
Stereotactic radiosurgery for brain metastases from malignant melanoma
por: Christ, Sebastian M., et al.
Publicado: (2015) -
An indirect treatment comparison of the efficacy of pembrolizumab versus competing regimens for the adjuvant treatment of stage III melanoma
por: Lorenzi, Maria, et al.
Publicado: (2019) -
Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases
por: Trembath, Dimitri G., et al.
Publicado: (2021)